Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × INDUSTRY × Radionuclide Generators × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Colorectal Neoplasms 1

Interventions

Paclitaxel 26 Cyclophosphamide 25 Cisplatin 25 Carboplatin 22 Bevacizumab 20 Nivolumab 19 pembrolizumab 18 Docetaxel 18 Rituximab 17 Fluorouracil 17 Dexamethasone 15 avelumab 14 Leucovorin 13 Gemcitabine 13 Ipilimumab 11 Capecitabine 11 fludarabine 10 atezolizumab 10 venetoclax 9 Radiotherapy 9 Cetuximab 9 ALT-803 9 130-nm albumin-bound paclitaxel 9 Pemetrexed 8 trametinib 7 Radiosurgery 7 Prednisone 7 Oxaliplatin 7 Lenalidomide 7 Bendamustine Hydrochloride 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡